Understanding and Overcoming Major Barriers in Cancer Nanomedicine
- 8 June 2010
- journal article
- Published by Taylor & Francis in Nanomedicine
- Vol. 5 (4), 523-528
- https://doi.org/10.2217/nnm.10.23
Abstract
No abstract availableThis publication has 51 references indexed in Scilit:
- Does a targeting ligand influence nanoparticle tumor localization or uptake?Trends in Biotechnology, 2008
- Nanotechnology and CancerAnnual Review of Medicine, 2008
- Detailed Identification of Plasma Proteins Adsorbed on Copolymer NanoparticlesAngewandte Chemie International Edition, 2007
- Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lungNature Biotechnology, 2007
- Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticlesProceedings of the National Academy of Sciences, 2007
- Parameters influencing the stealthiness of colloidal drug delivery systemsBiomaterials, 2006
- Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesInternational Journal of Pharmaceutics, 2006
- The use of nanocrystals in biological detectionNature Biotechnology, 2003
- Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors.1990
- A NEW CONCEPT FOR MACROMOLECULAR THERAPEUTICS IN CANCER-CHEMOTHERAPY - MECHANISM OF TUMORITROPIC ACCUMULATION OF PROTEINS AND THE ANTITUMOR AGENT SMANCS1986